TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Aurena Laboratories Holding AB
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
22,402
|
19,787
|
18,958 |
| Financial expenses |
271
|
148
|
92 |
| Earnings before taxes |
1,723
|
1,238
|
995 |
| EBITDA |
2,644
|
1,858
|
1,612 |
| Total assets |
19,472
|
17,737
|
16,733 |
| Current assets |
7,819
|
8,164
|
6,928 |
| Current liabilities |
4,028
|
4,791
|
3,145 |
| Equity capital |
10,559
|
9,355
|
9,311 |
| - share capital |
45
|
45
|
49 |
| Employees (average) |
79
|
76
|
76 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
54.2%
|
52.7%
|
55.6% |
| Turnover per employee |
284
|
260
|
249 |
| Profit as a percentage of turnover |
7.7%
|
6.3%
|
5.2% |
| Return on assets (ROA) |
10.2%
|
7.8%
|
6.5% |
| Current ratio |
194.1%
|
170.4%
|
220.3% |
| Return on equity (ROE) |
16.3%
|
13.2%
|
10.7% |
| Change turnover |
2,557
|
2,365
|
2,772 |
| Change turnover % |
13%
|
14%
|
17% |
| Chg. No. of employees |
3
|
0
|
2 |
| Chg. No. of employees % |
4%
|
0%
|
3% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.